The Trump administration has initiated an inquiry into those profiting off the exploitation of our children. President Trump’s Federal Trade Commission (FTC) is examining whether parents and the public were misled about the nature, risks, and permanence of so-called “gender-affirming care” for minors. This marks the first significant federal step toward scrutinizing practices that have, for years, been shielded by claims of “scientific consensus.”
For over a decade, pharmaceutical companies, medical institutions, and trans-activist groups have promoted puberty blockers, cross-sex hormones, and “gender transition” surgeries as necessary, even “life-saving,” treatments for confused children. These procedures were often described as reversible, safe, and supported by evidence. This was a perverse lie and the supposed “experts” within the government did nothing.
The FTC’s inquiry is designed to review whether the gender industry deliberately downplayed these risks and exaggerated the benefits of the experimental nature of these “treatments.” In particular, it is examining whether emotionally charged language, such as claims that not pursuing medical intervention leads to suicide, was used to pressure parents into consenting to procedures without fully understanding the consequences.
President Trump’s FTC needs Americans like you to show support for exposing the truth about so-called “gender-affirming care” by submitting a comment on their request for information.
>>> Stand with the Trump administration as they take on radical gender ideology <<<